Quantitative Fit Testing on Filtering Facepiece Respirators in Use by Peruvian Healthcare Workers Caring for Tuberculosis Patients during the COVID-19 Pandemic: PROFIT Study 2020

Jorge Inolopú, Kevin Mayma, Maricela Curisinche-Rojas, Rula Aylas, Juan A. Flores, Jaime Rosales-Rimache

Producción científica: Artículo CientíficoArtículo originalrevisión exhaustiva

1 Cita (Scopus)

Resumen

Background: The COVID-19 pandemic has promoted a shortage of filtering facepiece respirators (FFRs) and the emergence of new FFRs brands. We aimed to determine the fit provided by in-use FFRs in Peruvian healthcare workers (HCWs) during the COVID-19 pandemic. Methods: We enrolled 279 HCWs from 37 primary healthcare centers with highest burden of care for TB in Peru, of which 263 were assessed using quantitative fit tests (QNFT). Results were expressed as real-time fit factor (rt-FF) and overall fit factor (overall-FF), which was categorized as ≥100 (optimal result), 50–99, and <50. Results: We identified 3M 1860 FFRs (33.1%), Xiantao Zhong Yi ZYB-11 FFRs (24.6%) and Makrite 9500 FFRs (20.5%), mainly. Eighty-seven FFRs (33.1%) had an optimal overall-FF, 27 (10.3%) between 50–99, and 149 (56.6%) less than 50. Of the 87 FFRs with optimal overall-FF, 73 (83.9%) were 3M 1860 FFRs. Of the 27 FFRs with overall-FF between 50–99, 7 (25.9%) were Makrite 9500, while of the 149 with overall-FF less than 50, 58 (38.9%), and 47 (31.5%) were Xiantao Zhong Yi ZYB-11 and Makrite 9500, respectively. Conclusion: Xiantao Zhong Yi and Makrite FFRs do not adapt adequately to the face of Peruvian HCWs, most having fit factors less than 50.

Idioma originalInglés estadounidense
-6618
PublicaciónInternational Journal of Environmental Research and Public Health
Volumen20
N.º16
DOI
EstadoIndizado - ago. 2023
Publicado de forma externa

Nota bibliográfica

Publisher Copyright:
© 2023 by the authors.

Huella

Profundice en los temas de investigación de 'Quantitative Fit Testing on Filtering Facepiece Respirators in Use by Peruvian Healthcare Workers Caring for Tuberculosis Patients during the COVID-19 Pandemic: PROFIT Study 2020'. En conjunto forman una huella única.

Citar esto